Enphasys - Your partner in drug formulation

About us

Who we are

Enphasys provides services to evaluate the performance of oral (drug) formulations. Our aim is to accelerate drug development and to provide patients with well functioning and convenient oral drugs. We provide a range of state-of-the-art in vitro assays that evaluate the intestinal performance of various oral drug formulations.

Company

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Team

Invention

Our invention - ENA

The enabling absorption (ENA) device is a new in vitro tool that captures the complex dynamics between digestion and absorption in the small intestine. The ENA correctly ranks in vivo performance of advanced formulations of any type and the assay also provides mechanistic information to guide further optimization. Put simply, the top performing formulation in the ENA analysis is the one producing the highest oral bioavailability in vivo.

Book demo

New paper published corroborating ENA utility

August 10, 2023

A recent paper further corroborates the utility of Enphasys patented Enabling Absorption Device in evaluating performance of yet another type of oral drug formulation

Presentation at QRIOS VIP event

June 8, 2023

Enphasys invited to present at the QRIOS VIP event!

Enphasys selected to represent Swedish innovation in the U.S.

January 18, 2023

Daniel Bergström will represent Enphasys and its ground breaking technology for animal free oral drug formulation lead candidate selection at the upcoming SIREUS Entrepreneurship Forum in Colorado, USA, 14-17 Feb.